The ASAM Review Course in Addiction Medicine 2018 (20.5 CME)

image

Overview

The ASAM Review Course in Addiction Medicine is widely recognized as the essential primer for physicians and clinicians preparing for a career in addiction medicine, as well as for primary care providers who wish to increase their skills in identifying and managing patients whose medical problems are caused or exacerbated by substance use disorders.

The course offers two and a half days of sessions which are mapped to the addiction medicine exam blueprint of topics for the exam and features an outstanding faculty. Over 600 professionals attend this popular course each time it is offered. ASAM’s Review Course has had a major impact on advancing a common base of scientific knowledge among physicians and other healthcare professionals.

Learning Objectives

Upon completion, participants should be able to:

  1. Demonstrate practical knowledge on the neurobiology of addiction and articulate its activity in terms useful in a clinical setting
  2. Describe the effects of alcohol, tobacco and other drugs in both tolerant and non-tolerant individuals
  3. Describe the process for diagnosing addiction and differentiating the symptoms of addiction from those of other medical or psychiatric disorders
  4. Explain the various pharmacologic and psychosocial treatments for addictive disorders and describe the factors that should be considered in selecting a treatment modality to match the needs of a specific patient
  5. Describe the precipitants of relapse and current evidence-based practices to prevent and manage relapse

Additional Resources

Additional Board Exam Preparation resources and tools are also available.


  • Evaluation and Certificate - ASAM Review Course 2018

    Contains 2 Component(s), Medical Credits Offered

    CME Evaluation for the ASAM Review Course 2018

    Complete the course evaluation first and then claim credits. Attendees should claim only the credit commensurate with the extent of their participation in the activity.

  • Session 1: Neurobiology of Addiction (.75 CME)

    Contains 4 Component(s), Medical Credits Offered Recorded On: 07/26/2018

    Earn .75 AMA PRA Category 1 Credit(s) while learning aspects of The Neurobiology of Addiction likely to appear on the 2018 ABPM Certification Exam for Addiction Medicine, from this session recording from The ASAM Review Course in Addiction Medicine 2018.

    (.75 CME) In this session recording from The ASAM Review Course in Addiction Medicine 2018, the following topics are addressed: Animal Models of Addiction, Neuropharmacology, Acetylcholine, Norepinephrine, Dopamine, Serotonin, GammaAminobutyric Acid (GABA), Glutamate and NMDA Receptors , Other Amino Acids and Peptides, Endogenous Opioids, Endocannabinoids, Cellular and Molecular Mechanism in Addiction (Including NeuroAdaptation, Epigenetic Phenomena, etc.), NeuroImaging of Addiction and Related Phenomena (Craving, Relapse, Recovery, etc.)

    Petros Levounis

    MD, MA, DFASAM

    Dr. Levounis is a Phi Beta Kappa graduate of Stanford University where he studied chemistry and biophysics before receiving his medical education at Stanford University School of Medicine and the Medical College of Pennsylvania. During medical school, he received an MA degree in sociology from Stanford before moving to New York City where he trained in psychiatry at Columbia University. He graduated from Columbia receiving the National Institute of Mental Health Outstanding Resident Award and went on to complete his fellowship in addiction psychiatry at New York University. From 2002 to 2013, he served as director of the Addiction Institute of New York.
    Dr. Levounis has written numerous articles and monographs; has lectured extensively on addiction topics throughout the United States and abroad; and has been interviewed by all major television networks. Dr. Levounis serves on the Board of Directors of the American Society of Addiction Medicine (ASAM) and from 2005 to 2009 chaired the national Committee on Addiction Treatment of the American Psychiatric Association. Dr. Levounis is a Betty Ford Scholar, a recipient of a U.S. State Department Speaker and Specialist Award, a distinguished fellow of the APA and ASAM, and an honorary member of the World Psychiatric Association. 

    Dr. Levounis has published thirteen books including the self-help paperback “Sober Siblings: How to Help Your Alcoholic Brother or Sister—and Not Lose Yourself,” the textbook of “Substance Dependence and Co-Occurring Psychiatric Disorders,” “The Behavioral Addictions,” “Motivational Interviewing for Clinical Practice,” “Becoming Mindful,” and the “Office-Based Buprenorphine Treatment of Opioid Use Disorder,” now in its second edition. His books have been translated into German, Hungarian, Japanese, Portuguese, and Spanish. 

    Dr. Levounis is married to actor Lukas Hassel and lives in New York City.

  • Session 2: Alcohol (.75 CME)

    Contains 3 Component(s), Medical Credits Offered Recorded On: 07/26/2018

    Earn .75 AMA PRA Category 1 Credit(s) while learning aspects of Alcohol likely to appear on the 2018 ABPM Certification Exam for Addiction Medicine, from this session recording from The ASAM Review Course in Addiction Medicine 2018.

    (.75 CME) In this session recording from The ASAM Review Course in Addiction Medicine 2018, the following topics are addressed: Alcohol, Pharmacological Interventions for Alcohol Dependence, Management of Alcohol Intoxication and Withdrawal.

    Ricardo Restrepo

    MD, MPH

    Ricardo Restrepo Guzman MD, MPH finished his medical school in Medellin, Colombia. He completed his residency training in Psychiatry at Boston University Medical Center and a fellowship in Addiction Psychiatry at the same institution. He received a Master's degree in Global Public Health from New York University in 2008, while working at St Luke's Roosevelt Hospital Center, an academic institution affiliated with Columbia University, where he was the Director of the Addiction Psychopharmacology Clinic at the Addiction Institute of New York, as well as Attending Psychiatrist at the Adult Outpatient Clinic. 

    He remains affiliated with the Addiction Institute of New York as a faculty member. In 2012 he started to work at the Long Beach VA Hospital, where he is the Medical Director of the Substance Abuse Treatment Program/Buprenorphine Clinic as well as an Attending Psychiatrist at the Department of Mental Health. Ricardo holds an academic position as Assistant Clinical Professor of Psychiatry and Human Behavior at the University of California Irvine School of Medicine. He teaches and supervises students, psychiatry, family medicine residents and staff at the Long Beach VA Hospital and works with the diverse population of Los Angeles and Orange Counties. 

    His academic interests include the psychotherapy and psychopharmacology of addiction,the teaching of Psychiatry and Addiction Medicine around the United States and other countries. He is actively involved in issues related to transcultural psychiatry, human rights, and behavioral addictions. Ricardo has worked with immigrant populations in the United States for over 15 years. He is also a volunteer physician for Physicians for Human Rights (PHR}. He has conducted medical evaluations and clinical treatment of people who have survived torture and other forms of abuse,and has served as a United Nations Consultant since 2005. 

    Ricardo writes monthly for the Colombian healthcare newspaper EJ Pulso, among other publications in the medical field. He has written chapters for addiction and human rights textbooks. He Is the co-author of textbooks on buprenorphine as well as women's health and addiction. Most recently Ricardo cooperate with the APA/ DSM-5 Translation to Spanish language. He is board certified in Psychiatry and Addiction Psychiatry.

  • Session 3: Sedatives (.75 CME)

    Contains 3 Component(s), Medical Credits Offered Recorded On: 07/26/2018

    Earn .75 AMA PRA Category 1 Credit(s) while learning about Sedatives likely to appear on the 2018 ABPM Certification Exam for Addiction Medicine, from this session recording from The ASAM Review Course in Addiction Medicine 2018.

    (.75 CME) In this session recording from The ASAM Review Course in Addiction Medicine 2018, the following topics are addressed: Benzodiazepines, Benzodiazepine Receptor Agonists, Barbiturates and Other SedativeHypnotics, GHB, General Principles in Management of Intoxication and Withdrawal, Management of Sedative Hypnotic Intoxication and Withdrawal.

    Ricardo Restrepo

    MD, MPH

    Ricardo Restrepo Guzman MD, MPH finished his medical school in Medellin, Colombia. He completed his residency training in Psychiatry at Boston University Medical Center and a fellowship in Addiction Psychiatry at the same institution. He received a Master's degree in Global Public Health from New York University in 2008, while working at St Luke's Roosevelt Hospital Center, an academic institution affiliated with Columbia University, where he was the Director of the Addiction Psychopharmacology Clinic at the Addiction Institute of New York, as well as Attending Psychiatrist at the Adult Outpatient Clinic. 

    He remains affiliated with the Addiction Institute of New York as a faculty member. In 2012 he started to work at the Long Beach VA Hospital, where he is the Medical Director of the Substance Abuse Treatment Program/Buprenorphine Clinic as well as an Attending Psychiatrist at the Department of Mental Health. Ricardo holds an academic position as Assistant Clinical Professor of Psychiatry and Human Behavior at the University of California Irvine School of Medicine. He teaches and supervises students, psychiatry, family medicine residents and staff at the Long Beach VA Hospital and works with the diverse population of Los Angeles and Orange Counties. 

    His academic interests include the psychotherapy and psychopharmacology of addiction,the teaching of Psychiatry and Addiction Medicine around the United States and other countries. He is actively involved in issues related to transcultural psychiatry, human rights, and behavioral addictions. Ricardo has worked with immigrant populations in the United States for over 15 years. He is also a volunteer physician for Physicians for Human Rights (PHR}. He has conducted medical evaluations and clinical treatment of people who have survived torture and other forms of abuse,and has served as a United Nations Consultant since 2005. 

    Ricardo writes monthly for the Colombian healthcare newspaper EJ Pulso, among other publications in the medical field. He has written chapters for addiction and human rights textbooks. He Is the co-author of textbooks on buprenorphine as well as women's health and addiction. Most recently Ricardo cooperate with the APA/ DSM-5 Translation to Spanish language. He is board certified in Psychiatry and Addiction Psychiatry.

  • Session 4: Medical Co-Morbidities (.75 CME)

    Contains 3 Component(s), Medical Credits Offered Recorded On: 07/26/2018

    Earn .75 AMA PRA Category 1 Credit(s) while learning aspects of Medical Co-Morbidities likely to appear on the 2018 ABPM Certification Exam for Addiction Medicine, from this session recording from The ASAM Review Course in Addiction Medicine 2018.

    (.75 CME) In this session recording from The ASAM Review Course in Addiction Medicine 2018, the following topics are addressed: Management of Alcohol and Drug Withdrawal Among Those Hospitalized for an Acute CoMorbid Condition (Including Critical Care Detoxification), General Medical Evaluation and Management, General Medical and Surgical Complications, Cardiovascular Consequences, Hepatic Disorders, Other Gastrointestinal Disorders, Renal and Metabolic Disorders, Respiratory Disorders, Neurological Disorders, Infectious Diseases (HIV, TB, Sexually Transmitted Infections and Others), Hematologic Disorders, Sleep Disorders, Acute Traumatic Injuries, Rehabilitation From Traumatic Brain Injuries and Spinal Cord Injuries, Terminal Illness, Palliative medicine and EndofLife Issues, Endocrine and Reproductive Disorders

    Timothy K. Brennan

    MD, MPH, FASAM

    Timothy Brennan, MD, MPH, FASAM is an Addiction Medicine physician and Pediatrician. He is the Director of the Addiction Institute at Mount Sinai West and St. Luke's Hospitals in New York City and the Vice President for Medical and Academic Affairs at The Addiction Medicine Foundation. He is also the Director of the Fellowship in Addiction Medicine at the Icahn School of Medicine at Mount Sinai. He completed a Fellowship in Addiction Medicine at the Addiction Institute of New York, a Fellowship in Medical Ethics at Harvard Medical School, a Residency in Pediatrics at Weill Cornell Medical College / New York Presbyterian Hospital, and an Internship in Internal Medicine at Georgetown University Hospital. He is the Co-Editor of Essentials of Addiction Medicine and Board Certified in Addiction Medicine and Pediatrics.

  • Session 5: Ethics and the Law (.75 CME)

    Contains 3 Component(s), Medical Credits Offered Recorded On: 07/26/2018

    Earn .75 AMA PRA Category 1 Credit(s) while learning aspects of Ethics and the Law likely to appear on the 2018 ABPM Certification Exam for Addiction Medicine, from this session recording from The ASAM Review Course in Addiction Medicine 2018.

    (.75 CME) In this session recording from The ASAM Review Course in Addiction Medicine 2018, the following topics are addressed: Ethical issues in Addiction Practice, Informed Consent and Confidentiality in Clinical Practice and Clinical Research, Clinical and Legal Considerations in Prescribing Drugs for Treatment of Addiction, Clinical and Legal Considerations in the Treatment of Minors, Adolescent SchoolBased Drug Testing, Drug Courts and the Treatment of Incarcerated Populations, Licensing and Credentialing Issues for Health Professionals, Forensic Addiction Medicine: Expert Witness and Civil Commitment, Competency and the Assessment of Competence, Environmental Tobacco Smoke, Disability and Substance Use, Americans with Disabilities Act (ADA), Medical Futility and EndStage Addiction, Therapeutic Pessimism/Nihilism and PseudoFutility, Addiction Services Administration

    Timothy K. Brennan

    MD, MPH, FASAM

    Timothy Brennan, MD, MPH, FASAM is an Addiction Medicine physician and Pediatrician. He is the Director of the Addiction Institute at Mount Sinai West and St. Luke's Hospitals in New York City and the Vice President for Medical and Academic Affairs at The Addiction Medicine Foundation. He is also the Director of the Fellowship in Addiction Medicine at the Icahn School of Medicine at Mount Sinai. He completed a Fellowship in Addiction Medicine at the Addiction Institute of New York, a Fellowship in Medical Ethics at Harvard Medical School, a Residency in Pediatrics at Weill Cornell Medical College / New York Presbyterian Hospital, and an Internship in Internal Medicine at Georgetown University Hospital. He is the Co-Editor of Essentials of Addiction Medicine and Board Certified in Addiction Medicine and Pediatrics.

  • Session 6: Cannabis (.75 CME)

    Contains 3 Component(s), Medical Credits Offered Recorded On: 07/26/2018

    Earn .75 AMA PRA Category 1 Credit(s) while learning aspects of Cannabis likely to appear on the 2018 ABPM Certification Exam for Addiction Medicine, from this session recording from The ASAM Review Course in Addiction Medicine 2018.

    (.75 CME) In this session recording from The ASAM Review Course in Addiction Medicine 2018, the following topics are addressed: Cannabinoids, Management of Other Drug Intoxication and Withdrawal (Cannabinoids)

  • Session 7: Stimulants (.75 CME)

    Contains 3 Component(s), Medical Credits Offered Recorded On: 07/26/2018

    Earn .75 AMA PRA Category 1 Credit(s) while learning aspects of Stimulants likely to appear on the 2018 ABPM Certification Exam for Addiction Medicine, from this session recording from The ASAM Review Course in Addiction Medicine 2018.

    (.75 CME) In this session recording from The ASAM Review Course in Addiction Medicine 2018, the following topics are addressed: Cocaine, Amphetamine and Other Stimulants, MDMA, Management of Other Drug Intoxication and Withdrawal (Cocaine, Stimulants)

    Petros Levounis

    MD, MA, DFASAM

    Dr. Levounis is a Phi Beta Kappa graduate of Stanford University where he studied chemistry and biophysics before receiving his medical education at Stanford University School of Medicine and the Medical College of Pennsylvania. During medical school, he received an MA degree in sociology from Stanford before moving to New York City where he trained in psychiatry at Columbia University. He graduated from Columbia receiving the National Institute of Mental Health Outstanding Resident Award and went on to complete his fellowship in addiction psychiatry at New York University. From 2002 to 2013, he served as director of the Addiction Institute of New York.
    Dr. Levounis has written numerous articles and monographs; has lectured extensively on addiction topics throughout the United States and abroad; and has been interviewed by all major television networks. Dr. Levounis serves on the Board of Directors of the American Society of Addiction Medicine (ASAM) and from 2005 to 2009 chaired the national Committee on Addiction Treatment of the American Psychiatric Association. Dr. Levounis is a Betty Ford Scholar, a recipient of a U.S. State Department Speaker and Specialist Award, a distinguished fellow of the APA and ASAM, and an honorary member of the World Psychiatric Association. 

    Dr. Levounis has published thirteen books including the self-help paperback “Sober Siblings: How to Help Your Alcoholic Brother or Sister—and Not Lose Yourself,” the textbook of “Substance Dependence and Co-Occurring Psychiatric Disorders,” “The Behavioral Addictions,” “Motivational Interviewing for Clinical Practice,” “Becoming Mindful,” and the “Office-Based Buprenorphine Treatment of Opioid Use Disorder,” now in its second edition. His books have been translated into German, Hungarian, Japanese, Portuguese, and Spanish. 

    Dr. Levounis is married to actor Lukas Hassel and lives in New York City.

  • Session 8: Principles of Pharmacology and Toxicology (.75 CME)

    Contains 3 Component(s), Medical Credits Offered Recorded On: 07/26/2018

    Earn .75 AMA PRA Category 1 Credit(s) while learning aspects of Pharmacology and Toxicology likely to appear on the 201b ABPM Certification Exam for Addiction Medicine.

    (.75 CME) In this session recording from The ASAM Review Course in Addiction Medicine 2018, the following topics are addressed: Drug Metabolism and Principles of Drug Interactions (Including the Impact of Addictive Drug Use on the Metabolism of Common Therapeutic Medications), Reinforcement, Tolerance, CrossTolerance, Physical Dependence, Conditioning, Sensitization, Impact of Route of Drug Administration (Oral, Sublingual, Intravenous, Inhalation, Intramuscular, etc.), Alcohol and Drug Use in the Workplace: Clinical and Legal Considerations in Drug Testing, Workplace Drug Testing, Medical Review Officer (MRO) Responsibilities and Authority

    Timothy J. Wiegand

    MD, FACMT, FAACT, FASAM

    Tim Wiegand MD, DABAM, FACMT, FAACT was trained in internal medicine and completed fellowship training in Medical Toxicology at the University of California, San Francisco in 2006. He was the Medical Director of the Rochester Poison Center until 2010. Dr. Wiegand has been successful in developing a full time, bedside, medical toxicology consultation service and is very active in the practice of Addiction Medicine, having successfully completed his board certification recently. 

    In addition to his primary appointment as Associate Professor of Emergency Medicine at the University of Rochester School of Medicine & Dentistry in Rochester, NY, Dr. Wiegand serves as Medical Director for Huther Doyle Chemical Dependency Treatment Program in Rochester, NY and as a detoxification specialist for Syracuse Behavioral Health in Rochester, NY. 

    Dr. Wiegand serves on the New York Society of Addiction Medicine (NYSAM) Board of Directors as the Communication Committee Chair and he was recently elected to the American College of Medical Toxicology Board of Directors to begin a 3 year term in October, 2015. He currently serves as the chair of the Addiction Medicine Section for the American College of Medical Toxicology and he recently organized a very successful Addiction Medicine Academy for ACMT prior to their main Annual Scientific Meeting in Clearwater, Florida in March, 2015. Dr. Wiegand has presented for the ASAM Review Course on Pharmacology & Toxicology, MRO and drug testing principles at previous Review Course conferences.

  • Session 9: Behavioral Addictions (.75 CME)

    Contains 4 Component(s), Medical Credits Offered Recorded On: 07/27/2018

    Earn .75 AMA PRA Category 1 Credit(s) while learning aspects of Behavioral Addictions likely to appear on the 2018 ABPM Certification Exam for Addiction Medicine, from this session recording from The ASAM Review Course in Addiction Medicine 2018.

    (.75 CME) In this session recording from The ASAM Review Course in Addiction Medicine 2018, the following topics are addressed: Nonsubstance Addictions: Gambling, Sex, Food, Pharmacological Interventions for NonSubstance Related Addictions

The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The ASAM CME Committee and Reviewers Disclosure Listing

First Name Commercial Interests Compensation Received For what Role?
Timothy Brennan MD, MPH, FASAM None
Jeffrey DeVido MD Altria/Philip Morris Stock Inheritance
Paul Earley MD, DFASAM Alkermes, Inc; DynamiCare Health, Inc honoraria; Salary Speaker; VP of Medical Affairs 
James Finch MD, DFASAM None

Marc Fishman MD, DFASAM US World Meds; Alkermes consulting fee, travel; honoraria Consultant; Advisory board
David Galbis-Reig MD, DFASAM Ascension Wisconsin All Saints; Abbvie; Hospira; RespireRX Pharmaceuticals; Abbott Pharmaceuticals; Pfizer Bond Stock& Bond in Retirement IRA; Stock Options; Ownership Interests  Owner; Advisory board; PI; Consultant
Adam Gordon, MD, MPH None
Leslie Hayes, MD None
Abigail Herron DO, DFASAM None
Petros Levounis MD, MA, FASAM None
Carla Marienfeld MD None
Ricardo Restrepo MD, MPH, FASAM None
Richard Ries MD, DFASAM None
Edwin Salsitz MD, DFASAM None
Sharon Stancliff MD, FASAM None
Timothy Wiegand MD, FACMT, FAACT None
Erin Zerbo, MD None

ACCME Accreditation Statement:

The American Society of Addiction Medicine is accredited by the Accreditation Council for
Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA Credit Designation Statement:

The American Society of Addiction Medicine designates this live activity for a maximum of 20.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Academy of Family Physicians: 

This Live activity, The 2018 ASAM Review Course in Addiction Medicine & Pre-Courses, with a beginning date of 07/25/2018, has been reviewed and is acceptable for up to 27.50 Prescribed credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABAM Transitional Maintenance of Certification Program (Tmoc)

This course has been approved by The American Board of Addiction Medicine (ABAM).  Physicians enrolled in the Transitional Maintenance of Certification (Tmoc) Program can apply a maximum of 20.5 AMA PRA Category 1 Credits

American Psychological Association (APA)

The American Society of Addiction Medicine (ASAM) Continuing Medical Education (CME) has been approved for renewal of certification by the APA College of Professional Psychology. ASAM CME credits may be applied toward the APA’s “Certificate of Proficiency in the Treatment of Alcohol and Other Psychoactive Substance Use Disorders.”

Continuing Education Credits (CEUs)

Non-physician participants will receive a certificate of attendance upon completion of the activity and an online evaluation confirming their participation. Participants should submit his/her certificate of attendance to their professional organization/institute.

CME Committee Members

  • Catherine Friedman, MD, FASAM, Chair
  • R. Jeffrey Goldsmith, MD, DLFAPA, DFASAM
  • Adam J. Gordon, MD, MPH, FACP, DFASAM
  • Zwaantje Hamming, FNP-C, CARN-AP
  • Noel Ilogu, MD, MRCP, FASAM
  • Herbert L. Malinoff, MD, FACP, DFASAM
  • Edwin A. Salsitz, MD, DFASAM

Staff - Sandy Metcalfe; Arlene Deverman, MA, CAE, CFRE; Marcia Jackson, PhD

CME Committee, Program Planning Committee and Faculty Disclosure Information

In accordance with the disclosure policies of the American Society of Addiction Medicine (ASAM) and the Accreditation Council for Continuing Medical Education (ACCME), the effort is made to ensure balance, independence, objectivity, and scientific rigor in all educational activities. These polices include resolving all conflicts of interest between the CME Committee, planning committee and faculty, and commercial interests that might otherwise compromise the goal and educational integrity of this activity. All planning committee members and faculty participating in the activity have disclosed all relevant financial relationships with commercial interests. The ASAM CME Committee has reviewed these disclosures and determined that the planning committee and faculty relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity.

ACCME Accredited with Commendation

ACCME Accreditation Statement

The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA Credit Designation Statement

The American Society of Addiction Medicine designates this enduring material for a maximum of 20.5 AMA PRA Category 1 Credit(s).  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABPM Maintenance of Certification (MOC)

The American Board of Preventive Medicine (ABPM) has approved this activity for a maximum of 20.5 LLSA credits towards ABPM MOC Part II requirements.

ABAM Transitional Maintenance of Certification (tMOC)

This course has been approved by the American Board of Addiction Medicine (ABAM). Physicians enrolled in the ABAM Transitional Maintenance of Certification Program (tMOC) can apply a maximum of 20.5 AMA PRA Category 1 Credit(s)™ for completing this course.

Upon completion, participants should be able to:

  1. Demonstrate practical knowledge on the neurobiology of addiction and articulate its activity in terms useful in a clinical setting.
  2. Describe the effects of alcohol, tobacco and other drugs in both tolerant and non-tolerant individuals.
  3. Describe the process for diagnosing addiction and differentiating the symptoms of addiction from those of other medical or psychiatric disorders.
  4. Explain the various pharmacologic and psychosocial treatments for addictive disorders and describe the factors that should be considered in selecting a treatment modality to match the needs of a specific patient.
  5. Describe the precipitants of relapse and current evidence-based practices to prevent and manage relapse.

The ASAM Review Course in Addiction Medicine provides an up-to-date review of the core content of addiction medicine for:

  • Physicians preparing for the ABPM Board Certification/Recertification Examination in addiction medicine
  • Addiction specialists seeking a "refresher" course that incorporates recent developments in addiction science and practice
  • Non-specialist physicians and other healthcare professionals needing the knowledge to identify and manage problems related to substance use disorders for their patients